A.C. Braud
Impact in
- Oncology top 5%
- Colorectal Cancer Treatments and Studies
- Pancreatic and Hepatic Oncology Research
- Geriatrics and Gerontology top 5%
- Frailty in Older Adults
Papers in
-
- Breast Cancer Treatment Studies 7
-
- Frailty in Older Adults 2
- Co-authors
- Pascal Piedbois (2 shared papers)Marc E Buyse (2 shared papers)Jean‐Pierre Pignon (1 shared paper)M. O’Connell (1 shared paper)Robert W. Carlson (1 shared paper)Stefan Michiels (1 shared paper)Pierre Guillame Thirion (1 shared paper)Gilles F. Houvenaeghel (6 shared papers)
In The Last Decade
A.C. Braud
19 papers receiving 709 citations
Peers
Comparison fields: 5 of 36
- Oncology 311
- Geriatrics and Gerontology 40
- Cancer Research 86
- Surgery 72
- Hematology 20
Countries citing papers authored by A.C. Braud
This map shows the geographic impact of A.C. Braud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.C. Braud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.C. Braud more than expected).
Fields of papers citing papers by A.C. Braud
This network shows the impact of papers produced by A.C. Braud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.C. Braud. The network helps show where A.C. Braud may publish in the future.
Co-authors
The 25 scholars most cited alongside A.C. Braud, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 329 | |
| 2 | 2004 | 95 | |
| 3 | 2003 | 55 | |
| 4 | 2005 | 54 | |
| 5 | 2007 | 36 | |
| 6 | 2004 | 27 | |
| 7 | 2004 | 27 | |
| 8 | Phase I study of pegylated liposomal doxorubicin (Caelyx) in combination with carboplatin in patients with advanced solid tumors. | 2003 | 25 |
| 9 | 2003 | 20 | |
| 10 | 1999 | 18 | |
| 11 | 2003 | 15 | |
| 12 | 1999 | 12 | |
| 13 | High-dose alkylating agents with autologous hematopoietic stem cell support and trastuzumab in ERBB2 overexpressing metastatic breast cancer: a feasibility study. | 2005 | 11 |
| 14 | 2003 | 7 | |
| 15 | 2002 | 6 | |
| 16 | 2003 | 5 | |
| 17 | 2009 | 2 | |
| 18 | 2002 | 1 | |
| 19 | 2004 | 1 | |
| 20 | 2002 | 0 |
About A.C. Braud
A.C. Braud is a scholar working on Cancer Research, Geriatrics and Gerontology, Oncology, Hematology and Genetics, having authored 22 papers that have together received 746 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (7 papers), Colorectal Cancer Treatments and Studies (2 papers), Hematopoietic Stem Cell Transplantation (2 papers), Frailty in Older Adults (2 papers), Erythropoietin and Anemia Treatment (1 paper), Pancreatic and Hepatic Oncology Research (1 paper), Breast Implant and Reconstruction (1 paper) and HER2/EGFR in Cancer Research (1 paper). The work is most often cited by research in Oncology (311 citations), Geriatrics and Gerontology (40 citations), Cancer Research (86 citations), Surgery (72 citations) and Hematology (20 citations). A.C. Braud has collaborated with scholars based in France and Belgium. Frequent co-authors include Pascal Piedbois, Marc E Buyse, Jean‐Pierre Pignon, M. O’Connell, Robert W. Carlson, Stefan Michiels, Pierre Guillame Thirion, Gilles F. Houvenaeghel, Agnes Richard Tallet and Claire Julian‐Reynier. Their work appears in journals such as Bone Marrow Transplantation, Annals of Oncology, Annals of Surgical Oncology, International Journal of Radiation Oncology*Biology*Physics and European Journal of Surgical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.